dow-jones
Tyson Foods Is Maintained at Neutral by B of A Securities
(15:00 GMT) Tyson Foods Price Target Cut to $68.00/Share From $70.00 by B of A Securities
globenewswire
Vishay Intertechnology 34 PHE Multi-Turn Absolute Position Sensor Delivers High Accuracy and Stability at a Reduced Cost
10-Turn Device Offers Linearity Down to ± 1 %, Resolution of 1°, and a Lifespan of > 10 Million Cycles in a 7/8 in Diameter BodyMALVERN, Pa., July 02, 2026 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. NYSE:VSH today introduced a new ready-to-use multi-turn absolute position sensor designed for…
dow-jones
Blue Owl Capital's Redemption Requests Slow for Biggest Fund — Market Talk
Withdrawal requests for Blue Owl Capital's biggest private credit fund slowed in the latest quarter, soothing some jitters around the health of the private credit industry. Investors in the fund asked the firm to return 19% of shares outstanding in the fund in the second quarter, down from 22% in t…
The Show-Me Phase of the AI Trade has Arrived. 2 Strategies for Managing Risk. — Barrons.com
By Vishesh KumarThe rising tide of artificial intelligence was once lifting all boats in the tech trade. But three years into the boom, the waters are getting choppier. Investors are taking a show-me attitude. For financial advisors, limiting clients' downside risk and being mindful of volatility i…
zacks
Are Options Traders Betting on a Big Move in Ames National Stock?
Investors in Ames National Corporation ATLO need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2026 $22.50 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows h…
zacks
Can Centene's Integrated Healthcare Model Support Earnings Growth?
Centene Corporation's CNC integrated healthcare model is supporting its earnings potential by combining government-sponsored health plans with coordinated clinical services, pharmacy benefits and community-based care. This approach helps the company to manage medical costs more effectively while im…
dow-jones
BrightSpring Health Svcs Is Maintained at Buy by B of A Securities
(14:55 GMT) BrightSpring Health Svcs Price Target Raised to $77.00/Share From $66.00 by B of A Securities
zacks
Can AT&T's Build-A-Plan Expansion Strengthen Its Competitive Edge?
AT&T Inc. T is aiming to extend its Build-A-Plan offering to give customers greater flexibility, personalization and value across wireless and home Internet services. The updated offering intends to deliver a more seamless and convenient experience for customers both at home and outside.The enhance…
dow-jones
OpenAI Eyes 5% Stake for U.S. Government Ahead of IPO. 3 Ways the Company Could Benefit. — Barrons.com
By Adam ClarkOpenAI already has a lineup of impressive investors ahead of its eagerly awaited initial public offering. But the ChatGPT-developer would reportedly like to add one more name: the U.S. government.OpenAI has talked about offering a 5% ownership stake to the U.S. government, potentially…
zacks
Can ExxonMobil's Upstream Business Thrive With Oil Below $70?
Exxon Mobil Corporation XOM has a massive footprint in the Permian, the most prolific oil and gas play in the United States, and offshore Guyana. In the Permian, the integrated giant has been employing lightweight proppant technology and hence is capable of boosting its well recoveries by up to as…
dow-jones
argenx Is Maintained at Buy by B of A Securities
(14:51 GMT) argenx Price Target Raised to $1088.00/Share From $1016.00 by B of A Securities
quartr
RNAZ: Meeting adjourned to July 20, 2026, pending Nasdaq listing review completion
The meeting was called to order, a quorum was confirmed, and the Inspector of Election was appointed. The meeting was adjourned to allow time for Nasdaq to complete its review of the company's initial listing application, with the reconvened meeting scheduled for July 20, 2026.Based on TransCode Th…
AtaiBeckley Stock Outlook Depends on Key Pipeline Catalysts in 2026
AtaiBeckley ATAI is entering a catalyst-heavy period as its lead depression program moves closer to late-stage testing. The stock story is tied less to current revenue scale and more to whether its pipeline can validate new approaches in difficult mental health conditions.That setup gives growth-or…
zacks
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
Tango Therapeutics TNGX is becoming a clearer test of how precision oncology can shape biotech value in 2026. Its story now centers on MTAP-deleted cancers, synthetic lethality and targeted combinations.For investors, the issue is not whether Tango fits the trend. It does. The question is whether v…
dow-jones
IQM Quantum Computers Becomes First European Quantum Computing Company Listed on a Major U.S. Exchange
PRINCETON, N.J. & ESPOO, Finland--(BUSINESS WIRE)--July 02, 2026--IQM Quantum Computers NASDAQ:IQMX ("IQM", "IQM Quantum Computers" or the "Company"), a global leader in full-stack superconducting quantum computers, today became a publicly traded company following the completion of its business com…
dow-jones
Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
Radnostix Acquires Lucerno Dynamics Assets Expanding Radiopharma Medical Device Portfolio
dow-jones
Cheesecake Factory Is Maintained at Neutral by B of A Securities
(14:47 GMT) Cheesecake Factory Price Target Raised to $79.00/Share From $66.00 by B of A Securities
dow-jones
FactSet Research Is Maintained at Underperform by B of A Securities
(14:46 GMT) FactSet Research Price Target Raised to $210.00/Share From $205.00 by B of A Securities
zacks
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?
Tango Therapeutics TNGX has become one of 2026’s more dramatic biotechnology stories, with shares up 224.3% year to date and 404.1% over the past year.That rally reflects real clinical progress, but it also raises the bar. Tango remains a clinical-stage company with no approved products, no recurri…
quartr
CULP: Q4 sales and profitability improved sequentially, with cost savings and tariff refunds boosting outlook
Q4 saw sequential and year-over-year sales growth, driven by bedding segment momentum and operational efficiencies. Restructuring and integration initiatives yielded over $20 million in annualized savings, with tariff refunds set to further reduce debt and improve liquidity.Based on Culp, Inc. [CUL…